Literature DB >> 15734640

Making a new turn in matrix metalloprotease inhibition.

Zelda R Wasserman1.   

Abstract

The paradigm for matrix metalloprotease inhibition combines active site tailoring and catalytic zinc ligation. But, selectivity has been difficult. Now, Engel et al. present novel compounds, completely selective for MMP-13, with a unique binding mode.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734640     DOI: 10.1016/j.chembiol.2005.01.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  5 in total

1.  Allosteric inhibition of the neuropeptidase neurolysin.

Authors:  Christina S Hines; Kallol Ray; Jack J Schmidt; Fei Xiong; Rolf W Feenstra; Mia Pras-Raves; Jan Peter de Moes; Jos H M Lange; Manana Melikishvili; Michael G Fried; Paul Mortenson; Michael Charlton; Yogendra Patel; Stephen M Courtney; Chris G Kruse; David W Rodgers
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

2.  Modeling Structural Coordination and Ligand Binding in Zinc Proteins with a Polarizable Potential.

Authors:  Jiajing Zhang; Wei Yang; Jean-Philip Piquemal; Pengyu Ren
Journal:  J Chem Theory Comput       Date:  2012-01-02       Impact factor: 6.006

3.  A Cycloaddition Strategy for Use toward Berkelic Acid, an MMP Inhibitor and Potent Anticancer Agent Displaying a Unique Chroman Spiroketal Motif.

Authors:  Yaodong Huang; Thomas R R Pettus
Journal:  Synlett       Date:  2008-05-11       Impact factor: 2.454

Review 4.  Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects.

Authors:  Chen Zhang; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2009-03-31       Impact factor: 5.118

5.  Zinc deficiency impairs wound healing of colon anastomosis in rats.

Authors:  Marcel Binnebösel; Jochen Grommes; Benita Koenen; Karsten Junge; Christian D Klink; Michael Stumpf; Alexander P Ottinger; Volker Schumpelick; Uwe Klinge; Carsten J Krones
Journal:  Int J Colorectal Dis       Date:  2009-10-27       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.